University of Bern spinout Arctos Medical has been acquired by existing shareholder Novartis.
Arctos Medical, a Switzerland-based developer of gene therapies to restore sight that was spun out of University of Bern, was acquired by pharmaceutical firm Novartis for an undisclosed amount today.
Founded in 2012, Arctos Medical is working on optogenetics-based adeno-associated virus gene therapies to treat diseases that involve photoreceptor loss – causing blindness – such as inherited retinal dystrophies and age-related macular degeneration.
The technology was developed by Arctos’ scientific co-founders Sonja Kleinlogel and Michiel van Wyk.
…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
